Article
Current therapy guidelines for Waldenstrom's macroglobulinaemia.
Best practice & research. Clinical haematology - 1 Jun 2016
Kastritis Efstathios, Dimopoulos Meletios A
Abstract excerpt
Waldenstrom's macroglobulinaemia (WM) is a B-cell neoplasm in which bone marrow is infiltrated by lymphoplasmacytic cells that secrete monoclonal immunoglobulin M (IgM). More than a decade ago, specific criteria were agreed to define diagnosis and symptomatic disease requiring therapy; however, treatment recommendations change as new options emerge. Treatment decisions consider specific disease characteristics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.